Pooja Patil, Corporate Communication, B&R Industrial Automation, gives an insight on how pharma companies can digitise their operations, increase efficiencies, enhance product quality and fulfil regulatory compliances
INDUSTRY 4.0 IS ALL about creating seamless connectivity in between machines, processes and people within and beyond manufacturing facilities to increase quality, productivity and profit from the power of advanced data analytics. By these next-generation automation solutions, pharmaceutical manufacturing companies can digitise their operations, increase efficiencies, enhance product quality and fulfil regulatory compliances.
In addition, pharma companies are tasked with examining data at every stage of their manufacturing process, right from the time raw materials arrives until the final product is packed and sent for distribution. In traditional pharma facilities, the references and information about drug formulation, production and equipment and data of QA-QC are manually entered in data sheets, which are prone to human errors and can even be manipulated. With such non real-time information, it is difficult for management to take corrective actions and make timely decisions. However, with connected plant and IoT solutions, manufacturers can access data in real-time to monitor production, quality, overall equipment effectiveness (OEE) and condition of equipment. It also enables, mass customisation and batch size one with cost-effective production.
Improved operational efficiencies
With IoT, manufacturing facilities can monitor data from shop floors in real-time enhancing process efficiencies. In pharma industry, appropriate quality assurance is important. Without it, companies cannot guarantee that the product conforms to necessary quality and safety standards. Many a times, product quality suffers because of machine downtime. In such cases, monitoring conditions of assets in real time can help in increasing equipment availability, preventing unplanned downtime.
Diese Geschichte stammt aus der Express Pharma (Vol.13, No.16) June 16-30, 2018-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der Express Pharma (Vol.13, No.16) June 16-30, 2018-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Harnessing data analytics to propel drug discovery and development in 2025
As the pharma landscape evolves, data analytics will be at the forefront of drug discovery and development, transforming traditional methods. By leveraging data-driven insights, companies can expedite R&D, optimise clinical trials, and personalise treatments, bringing life-saving therapies to market more efficiently, explains Biju Davis, SVP, Engineering, Model N
Strengthening our presence within APAC through increased penetration is a key focus
Aanchal Tomar, Executive Director, Asia Pacific, Lonza Capsules Health Ingredients speaks about Lonza Capsules Health Ingredients’ strategic growth, challenges, and sustainability initiatives in the APAC market, showcasing their innovative capsule solutions and health ingredients that cater to the region's diverse pharmaceutical and nutraceutical needs, in an interview with Express Pharma
Responsible Sourcing and Manufacturing: Growing towards a sustainable future with Lonza
In response to the establishment of environmental impact targets by the pharmaceutical industry, Lonza promotes responsible sourcing practices, sustainable manufacturing standards, and renewable energy utilisation showcasing that responsible manufacturing can assist our customers to reach their sustainability goals, highlights Christine Lebeault, Head of Applied Sustainability, Lonza Capsules and Health Ingredients
Rethinking R&D to balance efficiency, innovation and sustainability
In an era of skyrocketing research costs and complex drug delivery challenges, pharma industry leaders share their insights on adopting advanced technologies, data-driven decision-making, and sustainable practices to optimise R&D and drive impactful therapies to market
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
